Abstract
SCFβ-TRCP suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2.
| Original language | English |
|---|---|
| Pages (from-to) | 1-19 |
| Number of pages | 19 |
| Journal | J EXPERIMENTAL MEDICINE |
| DOIs | |
| Publication status | Published - 2012 |
Keywords
- ANGIOGENESIS
- THYROID CARCINOMA
